BeOne Medicines (ONC) Change in Acquisitions & Divestments (2015 - 2025)

BeOne Medicines (ONC) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $1.6 million in Q4 2025.

• On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $3.4 million, a 29.79% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 29.79% from the prior year.
• Change in Acquisitions & Divestments for Q4 2025 stood at $1.6 million, down from $1.8 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for ONC reached as high as $1.1 billion in Q1 2021 and fell as low as -$10000.0 in Q4 2021.
• Historically, Change in Acquisitions & Divestments has averaged $333.4 million across 5 years, with a median of $211.2 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments plunged 100.0% in 2021 and surged 2112300.0% in 2022, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at -$10000.0 in 2021, then jumped by 2112300.0% to $211.2 million in 2022, then tumbled by 49.95% to $105.7 million in 2023, then sank by 97.49% to $2.7 million in 2024, then tumbled by 38.0% to $1.6 million in 2025.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $1.6 million in Q4 2025, $1.8 million in Q1 2025, and $2.7 million in Q1 2024.